Givaudan, CH0010645932

Givaudan stock gains 8.06 percent on SIX at EUR 4,058.00

Published on 10/13/2026 at 14:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Barclays raised its target to CHF 3,850 on October 5, 2026. Givaudan stock costs EUR 4,058.00 on October 13, 2026, up 8.06 percent on SIX.

Array
An isometric 3D illustration of a flavour and fragrance laboratory shown as a detailed cutaway view. Copper distillation columns and glass condensers fill one area. Benches hold test tubes and scent evaluation strips. Scientists in white lab coats work at
Givaudan CH0010645932 isometrisches Aromen-Labor mit kupfernen Destillationsanlagen, Probierstreifen und geordneten übersichtlichen Lagerbereichen, Illustration mit AI erstellt.

Givaudan (CH0010645932) was trading at EUR 4,058.00 at Lang & Schwarz on October 13, 2026 at 2:33 p.m. CEST, while its SIX quotation was up 8.06 percent in Swiss francs. The SIX share price stood at CHF 3,769.00 against a 52-week high of CHF 3,795.00.

Barclays raises its target

According to Investing.com on October 5, 2026, Barclays upgraded Givaudan from Equal Weight to Overweight and raised its price target from CHF 3,450.00 to CHF 3,850.00. The new target is 2.15 percent above the SIX price of CHF 3,769.00, using the same Swiss franc basis.

The revised target gives the analyst view a direct market test after the sharp move in the SIX quotation. Barclays cited stronger growth prospects for Taste & Wellbeing, while its published risk factors included raw-material inflation and weaker Fine Fragrance demand.

Stock position and valuation

Givaudan's 52-week range on SIX was CHF 2,566.00 to CHF 3,795.00. The current CHF 3,769.00 quotation is 0.69 percent below the upper end of that range, calculated against CHF 3,795.00.

The company had a market capitalization of CHF 34.8 billion on October 13, 2026. Its P/E ratio was 27.98, and its trailing dividend yield was 2.00 percent. These figures place the stock's valuation beside a high share-price position rather than alongside a low-range recovery.

Results date is January 27

Simply Wall St lists January 27, 2027 as Givaudan's next earnings date for fiscal year 2026. The date gives the market a defined checkpoint for testing the growth assumptions behind the CHF 3,850 target.

Comparison with peers

Givaudan (SIX, CHF): plus 8.06 percent, P/E 27.98, market capitalization CHF 34.8 billion
Symrise (Xetra, EUR): plus 3.22 percent, P/E 36.17, market capitalization EUR 13.2 billion
dsm-firmenich (Euronext Amsterdam, EUR): plus 3.65 percent, P/E minus 21.45, market capitalization EUR 25.5 billion

Price stays near the yearly high

At Lang & Schwarz, Givaudan was trading at EUR 4,058.00 on October 13, 2026 at 2:33 p.m. CEST. The SIX quotation was up 8.06 percent on the day, and the Swiss share price was CHF 3,769.00.

The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.

Givaudan stock facts

  • Company: Givaudan S.A.
  • ISIN: CH0010645932
  • Ticker: GIVN.SW
  • Primary exchange: SIX
  • Price Lang & Schwarz (as of October 13, 2026, 2:33 p.m. CEST): EUR 4,058.00
  • Change on SIX (October 13, 2026): plus 8.06 percent
  • Market capitalization: CHF 34.8 billion (as of October 13, 2026)
  • 52-week range: CHF 2,566.00-CHF 3,795.00 (as of October 13, 2026)
  • Sector / Industry: Basic Materials / Specialty Chemicals
  • Next earnings date: January 27, 2027

Market context: Market report SMI.

More news and analyses on Givaudan stock

Disclaimer...

en | CH0010645932 | GIVAUDAN | boerse | 70315059 | bgmi